The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Methods Matter -- Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors
Open accessPreprint — published as 10.1016/j.omtm.2020.05.018
Abstract
Different manufacturing approaches have been used in the production of recombinant adeno-associated virus (rAAV). The two leading approaches are transiently transfected human HEK293 cells and live baculovirus infection of Sf9 insect cells. Unexplained differences in vector performance have been seen clinically and preclinically. Thus, we performed for the first time a highly controlled comparative production analysis varying only the host cell species but keeping all other rAAV production parameters the same. We demonstrate that host cell species is critical for determining vector potency. Given these key findings, we then sought to deeply characterize differences in rAAVs when produced by these two manufacturing platforms with multiple analytical approaches including: proteomic profiling by mass spectrometry, isoelectric focusing, cryo-EM, denaturation assays, genomic and epigenomic sequencing of packaged genomes, human cytokine profiling, and comparative functional transduction assessments in vitro and in vivo , including in humanized liver mice. Using these tools we’ve made two major discoveries: 1) rAAV capsids have post-translational modifications (PTMs) including glycosylation, acetylation, phosphorylation, methylation and deamidation, and these PTMs differ between platforms; 2) rAAV genomes are methylated during production, and these methylation marks are also differentially deposited between platforms. In addition, our data also demonstrate that host cell protein impurities differ between platforms and can have their own PTMs including potentially immunogenic N-linked glycans. We show that human-produced rAAVs are more potent than baculovirus- Sf9 vectors in various cell types in vitro ( P < 0.05-0.0001), in various mouse tissues in vivo ( P < 0.03-0.0001), and in human liver in vivo ( P < 0.005). Collectively, our findings were reproducible across vendors, including commercial manufacturers, academic core facilities, and individual laboratory preparations. These vector differences may have clinical implications for rAAV receptor binding, trafficking, expression kinetics, expression durability, vector immunogenicity as well as cost considerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 3 Packaged rAAV Genomes Are Methylated during Production and Differentially Methylated Based on the Manufacturing Platform The five tracks of the Circos plot from the outside-in represent the following. First, a schematic of the ssAAV8 genome sequenced with key features labeled is shown (inverted terminal repeat [ITR], orange; intervening sequences, gray; EF1α promoter, red; firefly luciferase expression cassette, blue; woodchuck hepatitis virus posttranscriptional regulatory element [WPRE], plum; human growth hormone polyadenylation signal [hGHpA], magenta). Second, in blue, the methylation ratios for all detected sites for baculovirus-Sf9-produced rAAV8 are shown; the plotting represents a minimum of 0 and a maximum of 1 in 0.1 increments. Third, in red, the methylation ratios for all detected sites for human-produced rAAV are shown; scale same as previous. Fourth, in blue, the total numbers of reads at detected sites for baculovirus-Sf9 produced rAAV8 are shown; in log2 scale, from a minimum of 0 (total reads of 1) to a maximum of 11 (total reads of 211), in 0.1 increments. Fifth, in red, the total numbers of reads at detected sites for human-produced rAAV are shown; scale same as previous. The three sites with statistically significant differential methylation are highlighted in green (C:1208, C:2970, C:3779).](https://figures.cochat.ai/paper-figures/78bbfdddd3c14dd6ad0c41c22c28e3ac/methods-matter-standard-production-platforms-for-recombinant-aav-produce-figure-3.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It showed that the rAAV capsids can have post-translational modifications, such as glycosylation, that depend on the species origin of the production cell.”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, rAAVs produced in a human cell line (HEK293T) compared to baculovirus-Sf9 produced rAAVs were more potent in transfecting the liver in mice in vivo and in vitro (HEK293T, Huh7, human induced Pluripotent Stem Cells (hiPSCs), primary human fibroblasts, mouse C2C12 cells).”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“The rAAV production cell line and production cell line related impurities can influence the transduction efficiency in target tissue [44] (Sections 2 and 4.4).”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Circos: An information aesthetic for comparative genomics
Krzywinski, M., Schein, J., Birol, İ., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 10,964
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
ImageJ2: ImageJ for the next generation of scientific image data
Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena, E. T., & Eliceiri, K. W. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1934-z · Cited by 5,980
Elias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Function and information content of DNA methylation
Schübeler, D. (2015) · Nature · doi:10.1038/nature14192 · Cited by 2,060
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation
Zemach, A., McDaniel, I. E., Silva, P., & Zilberman, D. (2010) · Science · doi:10.1126/science.1186366 · Cited by 1,793
Conservation and divergence of methylation patterning in plants and animals
Feng, S., Cokus, S. J., Zhang, X., Chen, P.-Y., Bostick, M., Goll, M. G., Hetzel, J., Jain, J., Strauss, S. H., Halpern, M. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002720107 · Cited by 1,285
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273
g:Profiler—a web server for functional interpretation of gene lists (2016 update)
Reimand, J., Arak, T., Adler, P., Kolberg, L., Reisberg, S., Peterson, H., & Vilo, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw199 · Cited by 1,229
van Die, I. (2017) · Pure Amsterdam UMC · Cited by 1,112
Biopharmaceutical benchmarks 2014
Walsh, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3040 · Cited by 1,008
cisTEM, user-friendly software for single-particle image processing
Grant, T., Rohou, A., & Grigorieff, N. (2018) · eLife · doi:10.7554/elife.35383 · Cited by 865
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
Azuma, H., Paulk, N., Ranade, A., Dorrell, C., Al-Dhalimy, M., Ellis, E., Strom, S., Kay, M. A., Finegold, M., & Grompe, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1326 · Cited by 835
Self-citationNovel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Identification, analysis, and prediction of protein ubiquitination sites
Radivojac, P., Vacic, V., Haynes, C., Cocklin, R. R., Mohan, A., Heyen, J. W., Goebl, M. G., & Iakoucheva, L. M. (2010) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22555 · Cited by 583
High, K. A., & Roncarolo, M. G. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1706910 · Cited by 555
Nakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., & Kay, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6969-6976.2001 · Cited by 478
BCFtools/csq: haplotype-aware variant consequences
Danecek, P., & McCarthy, S. A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx100 · Cited by 468
Insect Cells as a Factory to Produce Adeno-Associated Virus Type 2 Vectors
Urabe, M., Ding, C., & Kotin, R. M. (2002) · Human Gene Therapy · doi:10.1089/10430340260355347 · Cited by 457
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
Lisowski, L., Dane, A. P., Chu, K., Zhang, Y., Cunningham, S. C., Wilson, E. M., Nygaard, S., Grompe, M., Alexander, I. E., & Kay, M. A. (2014) · Nature · doi:10.1038/nature12875 · Cited by 450
Akache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., & Kay, M. A. (2006) · Journal of Virology · doi:10.1128/jvi.00878-06 · Cited by 430
BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data
Guo, W., Fiziev, P., Yan, W., Cokus, S., Sun, X., Zhang, M. Q., Chen, P.-Y., & Pellegrini, M. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-774 · Cited by 420
Gaudet, D., Méthot, J., Déry, S., Brisson, D., Essiembre, C., Tremblay, G., Tremblay, K., de Wal, J., Twisk, J., van den Bulk, N., et al. (2013) · Gene Therapy · doi:10.1038/gt.2012.43 · Cited by 404
Grieger, J. C., Soltys, S. M., & Samulski, R. J. (2016) · Molecular Therapy · doi:10.1038/mt.2015.187 · Cited by 325
Ghaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A. (2012) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-28-147 · Cited by 320
Sonntag, F., Bleker, S., Leuchs, B., Fischer, R., & Kleinschmidt, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.01056-06 · Cited by 280
Smith, R. H., Levy, J. R., & Kotin, R. M. (2009) · Molecular Therapy · doi:10.1038/mt.2009.128 · Cited by 261
Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector
Nam, H.-J., Lane, M. D., Padron, E., Gurda, B., McKenna, R., Kohlbrenner, E., Aslanidi, G., Byrne, B., Muzyczka, N., Zolotukhin, S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01304-07 · Cited by 255
Davidoff, A. M., Ng, C. Y. C., Zhou, J., Spence, Y., & Nathwani, A. C. (2003) · Blood · doi:10.1182/blood-2002-09-2889 · Cited by 244
Venkatakrishnan, B., Yarbrough, J., Domsic, J., Bennett, A., Bothner, B., Kozyreva, O. G., Samulski, R. J., Muzyczka, N., McKenna, R., & Agbandje-McKenna, M. (2013) · Journal of Virology · doi:10.1128/jvi.02524-12 · Cited by 225
Subcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219
Tse, L. V., Klinc, K. A., Madigan, V. J., Castellanos Rivera, R. M., Wells, L. F., Havlik, L. P., Smith, J. K., Agbandje-McKenna, M., & Asokan, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704766114 · Cited by 210
Kronenberg, S., Böttcher, B., von der Lieth, C. W., Bleker, S., & Kleinschmidt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5296-5303.2005 · Cited by 198
Carbohydrate Epitopes and Their Relevance for the Diagnosis and Treatment of Allergic Diseases
van Ree, R. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000066770 · Cited by 188
N-Terminal Acetylation Inhibits Protein Targeting to the Endoplasmic Reticulum
Forte, G. M. A., Pool, M. R., & Stirling, C. J. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001073 · Cited by 180
Becerra, S. P., Koczot, F., Fabisch, P., & Rose, J. A. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2745-2754.1988 · Cited by 163
Paulk, N. K., Pekrun, K., Zhu, E., Nygaard, S., Li, B., Xu, J., Chu, K., Leborgne, C., Dane, A. P., Haft, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.09.021 · Cited by 161
Self-citationMietzsch, M., Grasse, S., Zurawski, C., Weger, S., Bennett, A. D., Agbandje‐McKenna, M., Muzyczka, N., Zolotukhin, S., & Heilbronn, R. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.184 · Cited by 156
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Malaker, S. A., Penny, S. A., Steadman, L. G., Myers, P. T., Loke, J. C. T., Raghavan, M., Bai, D. L., Shabanowitz, J., Hunt, D. F., & Cobbold, M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0280 · Cited by 143
Self-citationCapsid antibodies to different adeno-associated virus serotypes bind common regions
Gurda, B. L., DiMattia, M. A., Miller, E. B., Bennett, A., McKenna, R., Weichert, W. S., Nelson, C. D., Chen, W.-J., Muzyczka, N., Olson, N. H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00622-13 · Cited by 127
Alexander, I. E., Russell, D. W., Spence, A. M., & Miller, A. D. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.7-841 · Cited by 124
Giles, A. R., Sims, J. J., Turner, K. B., Govindasamy, L., Alvira, M. R., Lock, M. W., & Wilson, J. M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.09.013 · Cited by 124
Structure of Adeno-Associated Virus Type 4
Padron, E., Bowman, V. D., Kaludov, N. K., Govindasamy, L., Levy, H. C., Nick, P., McKENNA, R. V., Muzyczka, N., Chiorini, J. A., Baker, T. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5047-5058.2005 · Cited by 116
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.61 · Cited by 114
ngLOC: an n-gram-based Bayesian method for estimating the subcellular proteomes of eukaryotes
King, B. R., & Guda, C. (2007) · Genome biology · doi:10.1186/gb-2007-8-5-r68 · Cited by 102
Mapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8
Gurda, B. L., Raupp, C., Popa-Wagner, R., Naumer, M., Olson, N. H., Ng, R., McKENNA, R. V., Baker, T. S., Kleinschmidt, J. A., & Agbandje‐McKenna, M. (2012) · Journal of Virology · doi:10.1128/jvi.00218-12 · Cited by 101
Kondratov, O., Marsic, D., Crosson, S. M., Méndez‐Gómez, H. R., Moskalenko, O. V., Mietzsch, M., Heilbronn, R., Allison, J. R., Green, K. B., Agbandje‐McKenna, M., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.003 · Cited by 98
Aslanidi, G., Lamb, K. E., & Zolotukhin, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810614106 · Cited by 95
Liu, Q., Huang, W., Zhang, H., Wang, Y., Zhao, J., Song, A., Xie, H., Zhao, C., Gao, D., & Wang, Y. (2014) · Gene Therapy · doi:10.1038/gt.2014.47 · Cited by 93
Anisotropic Correction of Beam-induced Motion for Improved Single-particle Electron Cryo-microscopyPreprint
Zheng, S. Q., Palovcak, E. J., Armache, J., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/061960 · Cited by 89
Tseng, Y.-S., Gurda, B. L., Chipman, P. R., McKENNA, R. V., Afione, S. A., Chiorini, J. A., Muzyczka, N., Olson, N. H., Baker, T. S., Kleinschmidt, J. A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02710-14 · Cited by 72
CONFORMATIONAL STUDIES ON PROTEINS BY ISOELECTRIC FOCUSING*
Ui, N. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb47529.x · Cited by 69
Miller, E. B., Gurda, B. L., Govindasamy, L., McKENNA, R. V., Zolotukhin, S., Muzyczka, N., & Agbandje‐McKenna, M. (2006) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309106048184 · Cited by 63
Benskey, M. J., Sandoval, I. M., & Manfredsson, F. P. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2015.117 · Cited by 52
Murray, S., Nilsson, C. L., Hare, J. T., Emmett, M. R., Korostelev, A. A., Ongley, H. M., Marshall, A. G., & Chapman, M. S. (2006) · Journal of Virology · doi:10.1128/jvi.02417-05 · Cited by 43
Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
Dong, B., Duan, X., Chow, H. Y., Chen, L., Lu, H., Wu, W., Hauck, B., Wright, J. F., Kapranov, P., & Xiao, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086453 · Cited by 37
Vectored antibody gene delivery for the prevention or treatment of HIV infection
Deal, C. E., & Balazs, A. B. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000145 · Cited by 37
Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells
Rodrigues, A. F., Carrondo, M. J. T., Alves, P. M., & Coroadinha, A. S. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.09.010 · Cited by 34
Spatiotemporal mosaic self-patterning of pluripotent stem cells using CRISPR interference
Libby, A. R. G., Joy, D. A., So, P.-L., Mandegar, M. A., Muncie, J. M., Mendoza-Camacho, F. N., Weaver, V. M., Conklin, B. R., & McDevitt, T. C. (2018) · eLife · doi:10.7554/elife.36045 · Cited by 34
Galibert, L., Savy, A., Dickx, Y., Bonnin, D., Bertin, B., Mushimiyimana, I., van Oers, M. M., & Merten, O. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207414 · Cited by 26
Maynard, L. H., Smith, O., Tilmans, N. P., Tham, E., Hosseinzadeh, S., Tan, W., Leenay, R. T., May, A. P., & Paulk, N. K. (2019) · Human Gene Therapy Methods · doi:10.1089/hum.2019.110 · Cited by 24
Self-citationBioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal Muscle
Paulk, N. K., Pekrun, K., Charville, G. W., Maguire, K., Wosczyna, M. N., Xu, J., Zhang, Y., Lisowski, L., Yoo, B., Vilches-Moure, J. G., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.06.001 · Cited by 20
Self-citation
Research works printed but not linked: 3
- https://investors.biomarin.com/2019-01-07-BioMarin-Highlights-Key-Milestones-for-2019-at-37th-Annual-J-P-Morgan-Healthcare-Conference-in-San-Francisco.
- https://www.pfizer.com/news/press-release/press-release-detail/sangamo_and_pfizer_announce_phase_1_2_interim_data_for_investigational_hemophilia_a_gene_therapy.
- 2013, Phenix.real_space_refine, Computational Crystallography Newsletter, 4, 43
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 360
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Tan, E., Chin, C. S. H., Lim, Z. F. S., & Ng, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.796991 · Cited by 251
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Overcoming innate immune barriers that impede AAV gene therapy vectors
Muhuri, M., Maeda, Y., Ma, H., Ram, S., Fitzgerald, K. A., Tai, P. W. L., & Gao, G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143780 · Cited by 212
Metadata
- Authors
- Rumachik, N. G., Malaker, S. A., Poweleit, N., Maynard, L. H., Adams, C. M., Leib, R. D., Cirolia, G., Thomas, D., Stamnes, S., Holt, K., Sinn, P., May, A. P., & Paulk, N. K.
- Affiliations
- Stanford University (US)
- University of California, San Francisco (US)
- Chan Zuckerberg Biohub San Francisco (US)
- Cold Spring Harbor Laboratory (US)
- University of Iowa (US)
- Corresponding author
- Paulk, Nicole K.
- ORCID
- Venue
- Molecular Therapy — Methods & Clinical Development
- Publisher
- openRxiv
- Published
- 2019-05-17
- Volume
- 18
- Pages
- 98-118
- ISSN
- 2329-0501 (ISSN-L)
- PMC
- PMC7488757
- OpenAlex
- W3026609212
- Cited by
- 156
- References
- 71
- Citations by year
- 2026: 15 · 2025: 31 · 2024: 27 · 2023: 28 · 2022: 24 · 2021: 23 · 2020: 7 · 2019: 1
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Molecular Therapy — Methods & Clinical Development (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Howard Hughes Medical Institute
- Children's Hospital of Philadelphia
- University of Georgia
- National Institutes of Health (1s10od010786-01, HL51670, CA086862, DK54759)
- University of California, Davis
- University of California, San Francisco
- Holden Comprehensive Cancer Center, University of Iowa (P30-CA086862)
- National Heart, Lung, and Blood Institute (P01HL051670, U01HL145795, P01HL089707)
- National Cancer Institute (U01CA207702, P30CA086862)
- National Institute of General Medical Sciences (F32GM126663)
- National Institute of Allergy and Infectious Diseases (T32AI060537)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK107607, P30DK054759)
- National Institute of Environmental Health Sciences (U01ES032673)
- Genome Center, University of California, Davis (1S10OD010786-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- recombinant adeno-associated virus, transient transfection, post-translational modification, DNA methylation, vector immunogenicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.